Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)

被引:23
|
作者
Xiang, Zi-jun [1 ]
Hu, Tao [2 ]
Wang, Yun [1 ]
Wang, Hao [1 ]
Xu, Lin [3 ]
Cui, Ning [3 ]
机构
[1] Taihe Hosp, Ctr Liver Biliary Pancreat, Shiyan City, Hubei, Peoples R China
[2] Zhuxi Peoples Hosp, Dept Radiol, Shiyan City, Hubei, Peoples R China
[3] Taihe Hosp, Med Imaging Ctr Intervent Room, Shiyan City, Hubei, Peoples R China
关键词
CANCER; RESECTION; CYTOKINES; SURVIVAL; CELLS; INDEX;
D O I
10.1042/BSR20201190
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although the oncological outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) have markedly improved over the past decade, the survival prediction is still challenging. The aim of this study was to investigate the prognostic value of neutrophil-lymphocyte ratio (NLR) and analyze the relationship of between the NLR and immune cells phenotypes in patients with PDAC. Sixty-seven consecutive patients with PDAC were recruited in this study. Life-table estimates of survival time were calculated according to the Kaplan and Meier methodology. The phenotypic T cells subclasses were evaluated by flow cytometry. All the 67 patients in this study were treated with surgical resection and among them, 46 patients received adjuvant chemotherapy. Receiver operating characteristic (ROC) curves analysis was performed to compare prognostic value of NLR with CA199. We found that the Harrell's area under ROC (AUROC) for the NLR to predict overall survival (OS) (0.840; 95% CI, 0.766-0.898) was significantly higher than that of the CA199 levels. After that we stratified all patients into NLR > 2.5 (n = 42) and NLR <= 2.5 (n = 25) groups according to the OS of patients with PDAC. Survival analysis showed that patients with NLR <= 2.5 had significantly favorable OS and progressive free survival (PFS) compared with patients with NLR 2.5. The CD3+ and CD8+/CD28+ T cell subsets were significantly increased in patients with NLR <= 2.5 (P< 0.05), while the CD8+/CD28- and CD4+/CD25+ cell subsets were significantly decreased in patients with NLR <= 2.5 (P., 0.05). In conclusion, a high NLR value independently predicts poor survival in patients with PDAC after surgical resection. The NLR was closely related with immune cells phenotypes The NLR may help oncologists evaluate outcomes of patients received surgical resection and chemotherapy to choose alternative therapies for patients with high NLR value.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiform
    Lopes, M.
    Carvalho, B.
    Linhares, P.
    Vaz, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 447 - 447
  • [42] Neutrophil-lymphocyte ratio (NLR) as a prognostic factor in metastatic breast cancer
    Ayala de la Pena, F.
    Yufera Soler, J. C.
    Ivars, M. A.
    Fernandez Sanchez, A.
    Navarro Manzano, E.
    De la Morena Barrio, P.
    Garcia-Garre, E.
    Garcia-Martinez, E.
    Marin Zafra, G.
    Salguero Aguilar, R.
    Garcia, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson's disease subtypes
    Ucar, Ceyla Atac
    Cokal, Burcu Gokce
    Artik, Hanzade Aybuke Unal
    Inan, Levent Ertugrul
    Yoldas, Tahir Kurtulus
    NEUROLOGICAL SCIENCES, 2017, 38 (02) : 287 - 293
  • [44] Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study
    Hasegawa, Takumi
    Iga, Tomoya
    Takeda, Daisuke
    Amano, Rika
    Saito, Izumi
    Kakei, Yasumasa
    Kusumoto, Junya
    Kimoto, Akira
    Sakakibara, Akiko
    Akashi, Masaya
    BMC CANCER, 2020, 20 (01)
  • [45] Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study
    Takumi Hasegawa
    Tomoya Iga
    Daisuke Takeda
    Rika Amano
    Izumi Saito
    Yasumasa Kakei
    Junya Kusumoto
    Akira Kimoto
    Akiko Sakakibara
    Masaya Akashi
    BMC Cancer, 20
  • [46] Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy
    Kitsugi, Kensuke
    Kawata, Kazuhito
    Noritake, Hidenao
    Chida, Takeshi
    Ohta, Kazuyoshi
    Ito, Jun
    Takatori, Shingo
    Yamashita, Maho
    Hanaoka, Tomohiko
    Umemura, Masahiro
    Matsumoto, Moe
    Morita, Yoshifumi
    Takeda, Makoto
    Furuhashi, Satoru
    Kitajima, Ryo
    Muraki, Ryuta
    Ida, Shinya
    Matsumoto, Akio
    Suda, Takafumi
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [47] The contribution of neutrophil-lymphocyte ratio on prognosis in patients diagnosed with epidermal growth factor receptor mutant lung adenocarcinoma
    Kavurgaci, Suna
    Kabalak, Pinar Akin
    Kizilgoz, Derya
    Demirag, Funda
    Yilmaz, Ulku
    EURASIAN JOURNAL OF PULMONOLOGY, 2023, 25 (03) : 159 - 165
  • [48] Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma
    Yang Chen
    Huan Yan
    YanRong Wang
    Yan Shi
    GuangHai Dai
    Scientific Reports, 7
  • [49] Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma
    Chen, Yang
    Yan, Huan
    Wang, YanRong
    Shi, Yan
    Dai, GuangHai
    SCIENTIFIC REPORTS, 2017, 7
  • [50] Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma
    Abe, Tomoyuki
    Amano, Hironobu
    Kobayashi, Tsuyoshi
    Hanada, Keiji
    Nakahara, Masahiro
    Ohdan, Hideki
    Noriyuki, Toshio
    EJSO, 2018, 44 (10): : 1573 - 1579